menu toggle

Covered entity 

Comprehensive 340B solutions for covered entities 

  • Account setup and management: Streamline the setup of your 340B accounts to ensure seamless integration with your operations 
  • Orphan Drug Program participation: The orphan drug program provides access to voluntary manufacturer pricing and helps navigate complex restrictions effectively
  • Compliance support: Ensure adherence to 340B program requirements with our expert guidance on documentation, reporting tools, and compliance strategies
  • Audits and risk assessment: Proactively prepare for HRSA and manufacturer audits with our thorough audit support, minimizing risk and ensuring compliance

Unlock value through our enhanced Orphan Drug Program  

Navigating orphan drug restrictions and accessing voluntary manufacturer pricing can be a cumbersome process. Our Orphan Drug Program is designed to simplify this journey for you.  

 

Step 1:

NDC Identification

We begin by identifying all orphan drugs eligible for the program based on their National Drug Codes (NDCs). This ensures we focus on medications with potential cost savings through voluntary pricing agreements

Step 2:

Manufacturer outreach

Our dedicated team leverages our strong relationships with manufacturers to actively pursue voluntary pricing agreements on behalf of covered entities. This direct outreach streamlines the process and maximizes savings potential.   

Step 3:

Contract loading   

Once a voluntary pricing agreement is secured, we efficiently load the discounted pricing information into the 340B accounts of covered entities impacted by the orphan drug exclusion.  

Step 4:

Reporting and compliance   

We provide comprehensive reports to help you navigate manufacturer restrictions and seamlessly manage documentation required for HRSA and manufacturer audits, ensuring ongoing compliance.  

Navigate Orphan Drug complexities with Cencora  

With Cencora’s deep expertise in orphan drug programs, you can master complex regulations, secure the best contracts, and maximize your savings.  

Streamlined compliance

Comprehensive documentation and reporting tools help navigate manufacturer restrictions and audits  

Effortless contract facilitation

Leverage our extensive network to identify and secure the best voluntary pricing contracts for you  

Informed decision-making

Access an updated list of orphan drugs covered by voluntary pricing contracts to make smart business decisions

Maximize savings

Potentially save on drug costs and reduce the administrative burden associated with managing orphan drug lists and contracts  

Comprehensive 340B solutions  

Transform your 340B program with Cencora's tailored consulting and innovative solutions. Our ACE certified team excels in program enrollment, optimization, compliance, and audit readiness, supporting your goals every step of the way.  

Enhance your 340B program today   

Improve your 340B program operations and compliance efforts. Sign up for our newsletter to stay updated with the latest information and insights.  

Ready to elevate your 340B strategy?

We'd love to know what you're looking for and how we can help. Reach out and we'll start a conversation.